Transcriptional induction of SOX9 by NF-κB family member RelA in chondrogenic cells

Osteoarthritis and Cartilage

Volumn 17, Issue 8, 2009, Pages 1065-1075

  Ushita, M ^a   Saito, T ^a   Ikeda, T ^a   Yano, F ^a   Higashikawa, A ^a   Ogata, N ^a   Chung, U ^a   Nakamura, K ^a   Kawaguchi, H ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Chondrocyte; RelA; SOX9; Transcription

Indexed keywords

COLLAGEN TYPE 2; DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTOR SOX6; TRANSCRIPTION FACTOR SOX9;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ARTICULAR CARTILAGE; CELL DIFFERENTIATION; CHONDROGENESIS; CONTROLLED STUDY; DEVELOPMENTAL GENETICS; DNA FLANKING REGION; EMBRYO; FETUS; GENE ACTIVATION; GENE ACTIVITY; GENE DELETION; GENE SEQUENCE; GENETIC TRANSCRIPTION; HELA CELL; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; MUTAGENESIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN MOTIF; TANDEM REPEAT;

ANIMALS; CELLS, CULTURED; COLLAGEN TYPE II; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; NF-KAPPA B; PROMOTER REGIONS, GENETIC; SOX9 TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTORS;

EID: 67650395590     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joca.2009.02.003     Document Type: Article

References (44)

1. de Crombrugghe B., Lefebvre V., Behringer R.R., Bi W., Murakami S., and Huang W. Transcriptional mechanisms of chondrocyte differentiation. Matrix Biol 19 (2000) 389-394
2. Wright E., Hargrave M.R., Christiansen J., Cooper L., Kun J., Evans T., et al. The Sry-related gene SOX9 is expressed during chondrogenesis in mouse embryos. Nat Genet 9 (1995) 15-20
3. Healy C., Uwanogho D., and Sharpe P.T. Expression of the chicken SOX9 gene marks the onset of cartilage differentiation. Ann N Y Acad Sci 785 (1996) 261-262
4. Lefebvre V., Li P., and de Crombrugghe B. A new long form of SOX5 (LSOX5), SOX6 and SOX9 are coexpressed in chondrogenesis and cooperatively activate the type II collagen gene. EMBO J 17 (1998) 5718-5733
5. Lefebvre V., Huang W., Harley V.R., Goodfellow P.N., and de Crombrugghe B. SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene. Mol Cell Biol 17 (1997) 2336-2346
6. Bell D.M., Leung K.K., Wheatley S.C., Ng L.J., Zhou S., Ling K.W., et al. SOX9 directly regulates the type-II collagen gene. Nat Genet 16 (1997) 174-178
7. Bridgewater L.C., Lefebvre V., and de Crombrugghe B. Chondrocyte-specific enhancer elements in the Col11a2 gene resemble the Col2a1 tissue-specific enhancer. J Biol Chem 273 (1998) 14998-15006
8. Sekiya I., Tsuji K., Koopman P., Watanabe H., Yamada Y., Shinomiya K., et al. SOX9 enhances aggrecan gene promoter/enhancer activity and is up-regulated by retinoic acid in a cartilage-derived cell line, TC6. J Biol Chem 275 (2000) 10738-10744
9. Zhang P., Jimenez S.A., and Stokes D.G. Regulation of human COL9A1 gene expression. Activation of the proximal promoter region by SOX9. J Biol Chem 278 (2003) 117-123
10. Akiyama H., Chaboissier M.C., Martin J.F., Schedl A., and de Crombrugghe B. The transcription factor SOX9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of SOX5 and SOX6. Genes Dev 16 (2002) 2813-2828
11. Bi W., Deng J.M., Zhang Z., Behringer R.R., and de Crombrugghe B. SOX9 is required for cartilage formation. Nat Genet 22 (1999) 85-89
12. Bi W., Huang W., Whitworth D.J., Deng J.M., Zhang Z., Behringer R.R., et al. Haploinsufficiency of SOX9 results in defective cartilage primordia and premature skeletal mineralization. Proc Natl Acad Sci U S A 98 (2001) 6698-6703
13. Wagner T., Wirth J., Meyer J., Zabel B., Held M., Zimmer J., et al. Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9. Cell 79 (1994) 1111-1120
14. Ikeda T., Kamekura S., Mabuchi A., Kou I., Seki S., Takato T., et al. The combination of SOX5, SOX6, and SOX9 (the SOX trio) provides signals sufficient for induction of permanent cartilage. Arthritis Rheum 50 (2004) 3561-3573
15. Meffert M.K., and Baltimore D. Physiological functions for brain NF-κB. Trends Neurosci 28 (2005) 37-43
16. Li Q., Withoff S., and Verma I.M. Inflammation-associated cancer: NF-κB is the lynchpin. Trends Immunol 26 (2005) 318-325
17. Bonizzi G., and Karin M. The two NF-κB activation pathways and their role in innate and adaptive immunity. Trends Immunol 25 (2004) 280-288
18. Hayden M.S., and Ghosh S. Signaling to NF-κB. Genes Dev 18 (2004) 2195-2224
19. Chen L.F., and Greene W.C. Shaping the nuclear action of NF-κB. Nat Rev Mol Cell Biol 5 (2004) 392-401
20. Kanegae Y., Tavares A.T., Izpisua Belmonte J.C., and Verma I.M. Role of Rel/NF-κB transcription factors during the outgrowth of the vertebrate limb. Nature 392 (1998) 611-614
21. Takeda K., Takeuchi O., Tsujimura T., Itami S., Adachi O., and Kawai T. Limb and skin abnormalities in mice lacking IKKα. Science 284 (1999) 313-316
22. Li Q., Lu Q., Hwang J.Y., Buscher D., Lee K.F., Izpisua-Belmonte J.C., et al. IKK1-deficient mice exhibit abnormal development of skin and skeleton. Genes Dev 13 (1999) 1322-1328
23. Altschul S.F., Gish W., Miller W., Myers E.W., and Lipman D.J. Basic local alignment search tool. J Mol Biol 215 (1990) 403-410
24. Magne D., Bluteau G., Faucheux C., Palmar G., Viqnes-Colombeix C., Pilet P., et al. Phosphate is a specific signal for ATDC5 chondrocyte maturation and apoptosis-associated mineralization: possible implication of apoptosis in the regulation of endochondral ossification. J Bone Miner Res 18 (2003) 1430-1442
25. Ikeda T., Saito T., Ushita M., Yano F., Kan A., Itaka K., et al. Identification and characterization of the human SOX6 promoter. Biochem Biophys Res Commun 357 (2007) 383-390
26. Zhou G., Lefebvre V., Zhang Z., Eberspaecher H., and de Crombrugghe B. Three high mobility group-like sequences within a 48-base pair enhancer of the Col2a1 gene are required for cartilage-specific expression in vivo. J Biol Chem 273 (1998) 14989-14997
27. Morita S., Kojima T., and Kitamura T. Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther 7 (2000) 1063-1066
28. Morishita M., Kishino T., Furukawa K., Yonekura A., Miyazaki Y., Kanematsu T., et al. A 30-base-pair element in the first intron of SOX9 acts as an enhancer in ATDC5. Biochem Biophys Res Commun 288 (2001) 347-355
29. Kanai Y., and Koopman P. Structural and functional characterization of the mouse SOX9 promoter: implications for campomelic dysplasia. Hum Mol Genet 8 (1999) 691-696
30. Colter D.C., Piera-Velazquez S., Hawkins D.F., Whitecavage M.K., Jimenez S.A., and Stokes D.G. Regulation of the human SOX9 promoter by the CCAAT-binding factor. Matrix Biol 24 (2005) 185-197
31. Piera-Velazquez S., Hawkins D.F., Whitecavage M.K., Colter D.C., Stokes D.G., and Jimenez S.A. Regulation of the human SOX9 promotor by Sp1 and CREB. Exp Cell Res 313 (2007) 1069-1079
32. Wirth J., Wagner T., Meyer J., Pfeiffer R.A., Tietze H.U., Schempp W., et al. Translocation breakpoints in three patients with campomelic dysplasia and autosomal sex reversal map more than 130 kb from SOX9. Hum Genet 97 (1996) 186-193
33. Sil A.K., Maeda S., Sano Y., Roop D.R., and Karin M. IκB kinase-α acts in the epidermis to control skeletal and craniofacial morphogenesis. Nature 428 (2004) 660-664
34. Murakami S., Kan M., McKeehan W.L., and de Crombrugghe B. Up-regulation of the chondrogenic SOX9 gene by fibroblast growth factors is mediated by the mitogen-activated protein kinase pathway. Proc Natl Acad Sci U S A 97 (2000) 1113-1118
35. Zehentner B.K., Dony C., and Burtscher H. The transcription factor SOX9 is involved in BMP-2 signaling. J Bone Miner Res 14 (1999) 1734-1741
36. Semba I., Nonaka K., Takahashi I., Takahashi K., Dashner R., and Shum L. Positionally-dependent chondrogenesis induced by BMP4 is co-regulated by SOX9 and Msx2. Dev Dyn 217 (2000) 401-414
37. Sekiya I., Koopman P., Tsuji K., Mertin S., Harley V., Yamada Y., et al. Transcriptional suppression of SOX9 expression in chondrocytes by retinoic acid. J Cell Biochem 81 (2001) 71-78
38. Sitcheran R., Cogswell P.C., and Boldwin Jr. A.S. NF-κB mediates inhibition of mesenchymal cell differentiation through a posttranscriptional gene silencing mechanism. Genes Dev 17 (2003) 2368-2373
39. Silverman N., and Maniatis T. NF-κB signaling pathways in mammalian and insect innate immunity. Genes Dev 15 (2001) 2321-2342
40. Ghosh S., and Karin M. Missing pieces in the NF-κB puzzle. Cell 109 Suppl (2002) S81-S96
41. Li Q., and Verna I.M. NF-κB regulation in the immune system. Nat Rev Immunol 10 (2002) 725-734
42. Murakami S., Lefebvre V., and Crombrugghe B. Potent inhibition of the master chondrogenic factor SOX9 gene by interleukin-1 and tumor necrosis factor-α. J Biol Chem 275 (2000) 3687-3692
43. Olivotto E., Borzi R.M., Vitellotti R., Pagani S., Facchini A., Battistelli M., et al. Differential requirements for IKKα and IKKβ in the differentiation of primary human osteoarthritic chondrocytes. Arthritis Rheum 58 (2008) 227-239
44. Park M., Yong Y., Choi S.W., Kim J.H., Lee J.E., and Kim E.W. Constitutive RelA activation mediated by Nkx3.2 controls chondrocyte viability. Nat Cell Biol 9 (2007) 287-298